On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Association Genethon's own share of each project, not the project's full budget.
- Horizon 2020€7.7M · 10 projects
- FP7 (2007 to 2013)€6.9M · 7 projects
- Horizon Europe€1.0M · 3 projects
Projects
20 EU-funded projects, newest first. Association Genethon led 7 of them as coordinator. Each links to the official record.
- TEHCAssociated partner
Towards the Engineering of High-Capacity Viral Vectors for Neuromuscular Diseases
Horizon Europe · 2025–2027 · Project on CORDIS ↗
- ERDERAPartner
EUROPEAN RARE DISEASES RESEARCH ALLIANCE
Horizon Europe · 2024–2031 · Project on CORDIS ↗
€449ktheir share - AAVolutionPartner
Next-generation AAV vectors for liver-directed gene therapy
Horizon Europe · 2022–2027 · Project on CORDIS ↗
€591ktheir share - ARDATPartner
Accelerating Research & Development for Advanced Therapies
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€321ktheir share - MITOPOMPECoordinator
Targeting mitochondrial defects and oxidative stress in Pompe Disease: from pathogenesis to therapy
Horizon 2020 · 2019–2020 · Project on CORDIS ↗
€173ktheir share - UshTherPartner
Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€91ktheir share - CureCNCoordinator
Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€4.0Mtheir share - DMD2CURECoordinator
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach
Horizon 2020 · 2017–2019 · Project on CORDIS ↗
€185ktheir share - Muscle stress reliefPartner
Muscle Stress Relief: An integrated research program linking together basic research on secondary myopathies in stress states to innovative translation in applied myology.
Horizon 2020 · 2016–2020 · Project on CORDIS ↗
€131ktheir share - GLYCODIS3Coordinator
Genetic correction of glycogen debranching enzyme deficiency in Glycogen Storage disease III: a proof of concept study
Horizon 2020 · 2016–2017 · Project on CORDIS ↗
€173ktheir share - SCIDNETPartner
DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID)
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€800ktheir share - MYOCUREPartner
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€1.4Mtheir share - MIROCALSPartner
Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€374ktheir share - MOMAAVCoordinator
Molecular signatures and Modulation of immunity to Adeno-Associated Virus vectors
FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗
€810ktheir share - EUROFANCOLENPartner
Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€631ktheir share - NET4CGDCoordinator
Gene Therapy for X-linked Chronic Granulomatous Disease (CGD)
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
€2.3Mtheir share - GT-SKINCoordinator
Gene Therapy for Inherited Skin Adhesion Disorders
FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗
€2.2Mtheir share - GENEGRAFTPartner
Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector
FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗
€331ktheir share - €497ktheir share
- NMD-CHIPPartner
Development of targeted DNA-Chips for High Throughput Diagnosis of NeuroMuscular Disorders
FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗
€160ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 7 shared projects
- Assistance Publique Hopitaux de ParisFrance · 5 shared projects
- Medizinische Hochschule HannoverGermany · 5 shared projects
- University College LondonUnited Kingdom · 4 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 4 shared projects
- Genosafe SASFrance · 4 shared projects
- University College LondonUnited Kingdom · 3 shared projects
- Stichting Amsterdam UmcNetherlands · 3 shared projects
- Universitat Autonoma de BarcelonaSpain · 3 shared projects
- Sorbonne UniversiteFrance · 3 shared projects
- Deutsches Krebsforschungszentrum HeidelbergGermany · 3 shared projects
- Universitatsklinikum HeidelbergGermany · 3 shared projects
- Universitaetsklinikum FreiburgGermany · 3 shared projects
- Fondazione Telethon EtsItaly · 3 shared projects
- Eurofins Genomics Food-Environment-White Biotech Products and Services GmbHGermany · 3 shared projects
- Biontech Innovative Manufacturing Services GmbHGermany · 3 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- amyotrophic lateral sclerosis
- development studies
- diabetes
- drug discovery
- drug safety
- duchenne muscular dystrophy
- ecosystems
- enzymes
- gene therapy
- genomes
- graft versus host disease
- hematology
- immunology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
